Archive for MHRA Updates
Class 4 Medicines Defect Information: Mometasone Furoate 50 Microgram / Dose Nasal Spray, Suspension, PilsCo Ltd, EL (21)A/33
Source: MHRA Gov.uk 29.11.21 Error relating to the wording on the outer carton label for Mometasone Furoate 50 Microgram / Dose Nasal Spray, supplied by PilsCo Ltd. MDR Number...
Class 4 Medicines Defect Information: Diuril Oral Solution (unlicensed medicine), Mawdsley-Brooks & Company Limited, EL (21)A/32
Source: MHRA Gov.uk 29.11.21 Error with the patient information leaflet (PIL) that has been provided with Diuril Oral Solution, supplied by Mawdsley-Brooks & Company Limited. MDR Number MDR 241-11/21 Company...
Handpieces used in the phacoemulsification technique of cataract removal: need for careful cleaning (DSI/2021/009)
Source: MHRA / Govb.uk 24.11.21 Residue particles can end up in the patient’s eye. For the attention of decontamination specialists, theatre practitioners and anyone involved with the cleaning and decontamination...
Class 3 Medicines Recall: Martindale Pharma, an Ethypharm Group Company Methadone 5mg Tablets / Physeptone 5mg Tablets, EL (21)A/31
Source: MHRA/ Gov.uk 22.11.21 Martindale Pharma is recalling the below batch of Methadone 5mg tablets as a precautionary measure due to the discolouration of the PVdC film in a small...
Class 2 Medicines Recall: SANTEN Oy (trading as Santen UK Limited) and parallel distributor, IKERVIS 1 mg/mL eye drops, emulsion and VERKAZIA 1 mg/mL eye drops, emulsion, EL (21)A/30
Source: MHRA Gov.uk 18/11/21 SANTEN Oy (trading as Santen UK Limited) are recalling the above batches of products as a precautionary measure due to detection of particles/crystals of the active...
Class 4 Medicines Defect Information: Slenyto 1 mg and 5mg prolonged-release tablets – distributed by Flynn Pharma Ltd, EL (21)A/29
Source: MHRA / Gov.uk Flynn Pharma Ltd, distributors of Slenyto 1 mg and 5mg prolonged release tablets would like to notify you of an error with the patient information leaflets...
Investment and impact fund – inhaler prescribing
Source: NHSnetworks Four new indicators in the investment and impact fund (IIF) will support primary care teams in reducing carbon emissions from inhalers. Primary care networks (PCNs) are now rewarded...
Medicine Supply Notification: Xylocaine® 1% and 2% (lidocaine) with adrenaline 100micrograms/20ml solution for injection vials
Xylocaine® 1% and 2% (lidocaine) with adrenaline 100micrograms/20ml (1:200,000) solution for injection vials Tier 2 – medium impact* Date of issue: 8/11/2021 Link: https://www.sps.nhs.uk/shortages/shortage-of-lidocaine-adrenaline Summary • Xylocaine® 1% with adrenaline...
Medicines Supply Tool
Source: DHSC and NHSE/I Nov 2021 DHSC and NHSE/I in conjunction with the NHS Specialist Pharmacy Service have launched an online Medicines Supply Tool, which provides up to date information about...
Medicine Supply Notification
MSN/2021/052 Acebutolol (Sectral®) 100mg capsules Tier 2 – medium impact* Date of issue: 01/11/2021 Summary • Neon Healthcare are discontinuing acebutolol (Sectral®) 100mg capsules with stock expected to be exhausted...
Medicine Supply Notification MSN/2021/050 Latanoprost 50microgram/ml / timolol 5mg/ml (Fixapost®)0.2ml unit dose preservative free eye drops
Source: DHSC Tier 2 – medium impact* Date of issue: 27/10/2021 Summary • Fixapost® eye drops are out of stock until mid-November 2021. • Latanoprost (Monopost®) 50microgram/ml 0.2ml unit dose...
Class 3 Medicines Recall: Bimatoprost Aspire 0.3mg/ml eye drops, solution in single-dose container, Aspire Pharma Limited, EL (21)A/26
Source: MHRA Aspire Pharma Limited is recalling the below batches of Bimatoprost Aspire 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 as a precautionary measure. PL number...
